Global Next Generation Sequencing (NGS) Solution Supply, Demand and Key Producers, 2023-2029
The global Next Generation Sequencing (NGS) Solution market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Next Generation Sequencing (NGS) Solution demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Next Generation Sequencing (NGS) Solution, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Next Generation Sequencing (NGS) Solution that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Next Generation Sequencing (NGS) Solution total market, 2018-2029, (USD Million)
Global Next Generation Sequencing (NGS) Solution total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Next Generation Sequencing (NGS) Solution total market, key domestic companies and share, (USD Million)
Global Next Generation Sequencing (NGS) Solution revenue by player and market share 2018-2023, (USD Million)
Global Next Generation Sequencing (NGS) Solution total market by Type, CAGR, 2018-2029, (USD Million)
Global Next Generation Sequencing (NGS) Solution total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Next Generation Sequencing (NGS) Solution market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, PerkinElmer, Thermo Fisher Scientific, Roche Holding, Agilent Technologies, Myriad Genetics, Foundation Medicine, Oxford Nanopore Technologies and Pacific Biosciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Next Generation Sequencing (NGS) Solution market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Next Generation Sequencing (NGS) Solution Market, By Region:
1. How big is the global Next Generation Sequencing (NGS) Solution market?
2. What is the demand of the global Next Generation Sequencing (NGS) Solution market?
3. What is the year over year growth of the global Next Generation Sequencing (NGS) Solution market?
4. What is the total value of the global Next Generation Sequencing (NGS) Solution market?
5. Who are the major players in the global Next Generation Sequencing (NGS) Solution market?
6. What are the growth factors driving the market demand?
This report studies the global Next Generation Sequencing (NGS) Solution demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Next Generation Sequencing (NGS) Solution, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Next Generation Sequencing (NGS) Solution that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Next Generation Sequencing (NGS) Solution total market, 2018-2029, (USD Million)
Global Next Generation Sequencing (NGS) Solution total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Next Generation Sequencing (NGS) Solution total market, key domestic companies and share, (USD Million)
Global Next Generation Sequencing (NGS) Solution revenue by player and market share 2018-2023, (USD Million)
Global Next Generation Sequencing (NGS) Solution total market by Type, CAGR, 2018-2029, (USD Million)
Global Next Generation Sequencing (NGS) Solution total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Next Generation Sequencing (NGS) Solution market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, PerkinElmer, Thermo Fisher Scientific, Roche Holding, Agilent Technologies, Myriad Genetics, Foundation Medicine, Oxford Nanopore Technologies and Pacific Biosciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Next Generation Sequencing (NGS) Solution market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Next Generation Sequencing (NGS) Solution Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Whole Genome Sequencing
- Whole Exome Sequencing
- Targeted Sequencing and Resequencing Centrifuges
- Sporadic Cancer
- Inherited Cancer
- Companion Diagnostics
- Others
- Illumina
- PerkinElmer
- Thermo Fisher Scientific
- Roche Holding
- Agilent Technologies
- Myriad Genetics
- Foundation Medicine
- Oxford Nanopore Technologies
- Pacific Biosciences
- Paradigm Diagnostics
- BGI Group
- Caris Life Sciences
- Partek
- Eurofins Scientific
- Qiagen
1. How big is the global Next Generation Sequencing (NGS) Solution market?
2. What is the demand of the global Next Generation Sequencing (NGS) Solution market?
3. What is the year over year growth of the global Next Generation Sequencing (NGS) Solution market?
4. What is the total value of the global Next Generation Sequencing (NGS) Solution market?
5. Who are the major players in the global Next Generation Sequencing (NGS) Solution market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Next Generation Sequencing (NGS) Solution Introduction
1.2 World Next Generation Sequencing (NGS) Solution Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Next Generation Sequencing (NGS) Solution Total Market by Region (by Headquarter Location)
1.3.1 World Next Generation Sequencing (NGS) Solution Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Next Generation Sequencing (NGS) Solution Market Size (2018-2029)
1.3.3 China Next Generation Sequencing (NGS) Solution Market Size (2018-2029)
1.3.4 Europe Next Generation Sequencing (NGS) Solution Market Size (2018-2029)
1.3.5 Japan Next Generation Sequencing (NGS) Solution Market Size (2018-2029)
1.3.6 South Korea Next Generation Sequencing (NGS) Solution Market Size (2018-2029)
1.3.7 ASEAN Next Generation Sequencing (NGS) Solution Market Size (2018-2029)
1.3.8 India Next Generation Sequencing (NGS) Solution Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Next Generation Sequencing (NGS) Solution Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Next Generation Sequencing (NGS) Solution Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029)
2.2 World Next Generation Sequencing (NGS) Solution Consumption Value by Region
2.2.1 World Next Generation Sequencing (NGS) Solution Consumption Value by Region (2018-2023)
2.2.2 World Next Generation Sequencing (NGS) Solution Consumption Value Forecast by Region (2024-2029)
2.3 United States Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029)
2.4 China Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029)
2.5 Europe Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029)
2.6 Japan Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029)
2.7 South Korea Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029)
2.8 ASEAN Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029)
2.9 India Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029)
3 WORLD NEXT GENERATION SEQUENCING (NGS) SOLUTION COMPANIES COMPETITIVE ANALYSIS
3.1 World Next Generation Sequencing (NGS) Solution Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Next Generation Sequencing (NGS) Solution Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Next Generation Sequencing (NGS) Solution in 2022
3.2.3 Global Concentration Ratios (CR8) for Next Generation Sequencing (NGS) Solution in 2022
3.3 Next Generation Sequencing (NGS) Solution Company Evaluation Quadrant
3.4 Next Generation Sequencing (NGS) Solution Market: Overall Company Footprint Analysis
3.4.1 Next Generation Sequencing (NGS) Solution Market: Region Footprint
3.4.2 Next Generation Sequencing (NGS) Solution Market: Company Product Type Footprint
3.4.3 Next Generation Sequencing (NGS) Solution Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Next Generation Sequencing (NGS) Solution Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Next Generation Sequencing (NGS) Solution Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Next Generation Sequencing (NGS) Solution Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Next Generation Sequencing (NGS) Solution Consumption Value Comparison
4.2.1 United States VS China: Next Generation Sequencing (NGS) Solution Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Next Generation Sequencing (NGS) Solution Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Next Generation Sequencing (NGS) Solution Companies and Market Share, 2018-2023
4.3.1 United States Based Next Generation Sequencing (NGS) Solution Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Next Generation Sequencing (NGS) Solution Revenue, (2018-2023)
4.4 China Based Companies Next Generation Sequencing (NGS) Solution Revenue and Market Share, 2018-2023
4.4.1 China Based Next Generation Sequencing (NGS) Solution Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Next Generation Sequencing (NGS) Solution Revenue, (2018-2023)
4.5 Rest of World Based Next Generation Sequencing (NGS) Solution Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Next Generation Sequencing (NGS) Solution Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Next Generation Sequencing (NGS) Solution Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Next Generation Sequencing (NGS) Solution Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Whole Genome Sequencing
5.2.2 Whole Exome Sequencing
5.2.3 Targeted Sequencing and Resequencing Centrifuges
5.3 Market Segment by Type
5.3.1 World Next Generation Sequencing (NGS) Solution Market Size by Type (2018-2023)
5.3.2 World Next Generation Sequencing (NGS) Solution Market Size by Type (2024-2029)
5.3.3 World Next Generation Sequencing (NGS) Solution Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Next Generation Sequencing (NGS) Solution Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Sporadic Cancer
6.2.2 Inherited Cancer
6.2.3 Companion Diagnostics
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Next Generation Sequencing (NGS) Solution Market Size by Application (2018-2023)
6.3.2 World Next Generation Sequencing (NGS) Solution Market Size by Application (2024-2029)
6.3.3 World Next Generation Sequencing (NGS) Solution Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Illumina
7.1.1 Illumina Details
7.1.2 Illumina Major Business
7.1.3 Illumina Next Generation Sequencing (NGS) Solution Product and Services
7.1.4 Illumina Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Illumina Recent Developments/Updates
7.1.6 Illumina Competitive Strengths & Weaknesses
7.2 PerkinElmer
7.2.1 PerkinElmer Details
7.2.2 PerkinElmer Major Business
7.2.3 PerkinElmer Next Generation Sequencing (NGS) Solution Product and Services
7.2.4 PerkinElmer Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 PerkinElmer Recent Developments/Updates
7.2.6 PerkinElmer Competitive Strengths & Weaknesses
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Details
7.3.2 Thermo Fisher Scientific Major Business
7.3.3 Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Product and Services
7.3.4 Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Thermo Fisher Scientific Recent Developments/Updates
7.3.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.4 Roche Holding
7.4.1 Roche Holding Details
7.4.2 Roche Holding Major Business
7.4.3 Roche Holding Next Generation Sequencing (NGS) Solution Product and Services
7.4.4 Roche Holding Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Roche Holding Recent Developments/Updates
7.4.6 Roche Holding Competitive Strengths & Weaknesses
7.5 Agilent Technologies
7.5.1 Agilent Technologies Details
7.5.2 Agilent Technologies Major Business
7.5.3 Agilent Technologies Next Generation Sequencing (NGS) Solution Product and Services
7.5.4 Agilent Technologies Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Agilent Technologies Recent Developments/Updates
7.5.6 Agilent Technologies Competitive Strengths & Weaknesses
7.6 Myriad Genetics
7.6.1 Myriad Genetics Details
7.6.2 Myriad Genetics Major Business
7.6.3 Myriad Genetics Next Generation Sequencing (NGS) Solution Product and Services
7.6.4 Myriad Genetics Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Myriad Genetics Recent Developments/Updates
7.6.6 Myriad Genetics Competitive Strengths & Weaknesses
7.7 Foundation Medicine
7.7.1 Foundation Medicine Details
7.7.2 Foundation Medicine Major Business
7.7.3 Foundation Medicine Next Generation Sequencing (NGS) Solution Product and Services
7.7.4 Foundation Medicine Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Foundation Medicine Recent Developments/Updates
7.7.6 Foundation Medicine Competitive Strengths & Weaknesses
7.8 Oxford Nanopore Technologies
7.8.1 Oxford Nanopore Technologies Details
7.8.2 Oxford Nanopore Technologies Major Business
7.8.3 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Product and Services
7.8.4 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Oxford Nanopore Technologies Recent Developments/Updates
7.8.6 Oxford Nanopore Technologies Competitive Strengths & Weaknesses
7.9 Pacific Biosciences
7.9.1 Pacific Biosciences Details
7.9.2 Pacific Biosciences Major Business
7.9.3 Pacific Biosciences Next Generation Sequencing (NGS) Solution Product and Services
7.9.4 Pacific Biosciences Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Pacific Biosciences Recent Developments/Updates
7.9.6 Pacific Biosciences Competitive Strengths & Weaknesses
7.10 Paradigm Diagnostics
7.10.1 Paradigm Diagnostics Details
7.10.2 Paradigm Diagnostics Major Business
7.10.3 Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Product and Services
7.10.4 Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Paradigm Diagnostics Recent Developments/Updates
7.10.6 Paradigm Diagnostics Competitive Strengths & Weaknesses
7.11 BGI Group
7.11.1 BGI Group Details
7.11.2 BGI Group Major Business
7.11.3 BGI Group Next Generation Sequencing (NGS) Solution Product and Services
7.11.4 BGI Group Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 BGI Group Recent Developments/Updates
7.11.6 BGI Group Competitive Strengths & Weaknesses
7.12 Caris Life Sciences
7.12.1 Caris Life Sciences Details
7.12.2 Caris Life Sciences Major Business
7.12.3 Caris Life Sciences Next Generation Sequencing (NGS) Solution Product and Services
7.12.4 Caris Life Sciences Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Caris Life Sciences Recent Developments/Updates
7.12.6 Caris Life Sciences Competitive Strengths & Weaknesses
7.13 Partek
7.13.1 Partek Details
7.13.2 Partek Major Business
7.13.3 Partek Next Generation Sequencing (NGS) Solution Product and Services
7.13.4 Partek Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Partek Recent Developments/Updates
7.13.6 Partek Competitive Strengths & Weaknesses
7.14 Eurofins Scientific
7.14.1 Eurofins Scientific Details
7.14.2 Eurofins Scientific Major Business
7.14.3 Eurofins Scientific Next Generation Sequencing (NGS) Solution Product and Services
7.14.4 Eurofins Scientific Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Eurofins Scientific Recent Developments/Updates
7.14.6 Eurofins Scientific Competitive Strengths & Weaknesses
7.15 Qiagen
7.15.1 Qiagen Details
7.15.2 Qiagen Major Business
7.15.3 Qiagen Next Generation Sequencing (NGS) Solution Product and Services
7.15.4 Qiagen Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Qiagen Recent Developments/Updates
7.15.6 Qiagen Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Next Generation Sequencing (NGS) Solution Industry Chain
8.2 Next Generation Sequencing (NGS) Solution Upstream Analysis
8.3 Next Generation Sequencing (NGS) Solution Midstream Analysis
8.4 Next Generation Sequencing (NGS) Solution Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Next Generation Sequencing (NGS) Solution Introduction
1.2 World Next Generation Sequencing (NGS) Solution Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Next Generation Sequencing (NGS) Solution Total Market by Region (by Headquarter Location)
1.3.1 World Next Generation Sequencing (NGS) Solution Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Next Generation Sequencing (NGS) Solution Market Size (2018-2029)
1.3.3 China Next Generation Sequencing (NGS) Solution Market Size (2018-2029)
1.3.4 Europe Next Generation Sequencing (NGS) Solution Market Size (2018-2029)
1.3.5 Japan Next Generation Sequencing (NGS) Solution Market Size (2018-2029)
1.3.6 South Korea Next Generation Sequencing (NGS) Solution Market Size (2018-2029)
1.3.7 ASEAN Next Generation Sequencing (NGS) Solution Market Size (2018-2029)
1.3.8 India Next Generation Sequencing (NGS) Solution Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Next Generation Sequencing (NGS) Solution Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Next Generation Sequencing (NGS) Solution Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029)
2.2 World Next Generation Sequencing (NGS) Solution Consumption Value by Region
2.2.1 World Next Generation Sequencing (NGS) Solution Consumption Value by Region (2018-2023)
2.2.2 World Next Generation Sequencing (NGS) Solution Consumption Value Forecast by Region (2024-2029)
2.3 United States Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029)
2.4 China Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029)
2.5 Europe Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029)
2.6 Japan Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029)
2.7 South Korea Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029)
2.8 ASEAN Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029)
2.9 India Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029)
3 WORLD NEXT GENERATION SEQUENCING (NGS) SOLUTION COMPANIES COMPETITIVE ANALYSIS
3.1 World Next Generation Sequencing (NGS) Solution Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Next Generation Sequencing (NGS) Solution Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Next Generation Sequencing (NGS) Solution in 2022
3.2.3 Global Concentration Ratios (CR8) for Next Generation Sequencing (NGS) Solution in 2022
3.3 Next Generation Sequencing (NGS) Solution Company Evaluation Quadrant
3.4 Next Generation Sequencing (NGS) Solution Market: Overall Company Footprint Analysis
3.4.1 Next Generation Sequencing (NGS) Solution Market: Region Footprint
3.4.2 Next Generation Sequencing (NGS) Solution Market: Company Product Type Footprint
3.4.3 Next Generation Sequencing (NGS) Solution Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Next Generation Sequencing (NGS) Solution Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Next Generation Sequencing (NGS) Solution Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Next Generation Sequencing (NGS) Solution Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Next Generation Sequencing (NGS) Solution Consumption Value Comparison
4.2.1 United States VS China: Next Generation Sequencing (NGS) Solution Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Next Generation Sequencing (NGS) Solution Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Next Generation Sequencing (NGS) Solution Companies and Market Share, 2018-2023
4.3.1 United States Based Next Generation Sequencing (NGS) Solution Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Next Generation Sequencing (NGS) Solution Revenue, (2018-2023)
4.4 China Based Companies Next Generation Sequencing (NGS) Solution Revenue and Market Share, 2018-2023
4.4.1 China Based Next Generation Sequencing (NGS) Solution Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Next Generation Sequencing (NGS) Solution Revenue, (2018-2023)
4.5 Rest of World Based Next Generation Sequencing (NGS) Solution Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Next Generation Sequencing (NGS) Solution Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Next Generation Sequencing (NGS) Solution Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Next Generation Sequencing (NGS) Solution Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Whole Genome Sequencing
5.2.2 Whole Exome Sequencing
5.2.3 Targeted Sequencing and Resequencing Centrifuges
5.3 Market Segment by Type
5.3.1 World Next Generation Sequencing (NGS) Solution Market Size by Type (2018-2023)
5.3.2 World Next Generation Sequencing (NGS) Solution Market Size by Type (2024-2029)
5.3.3 World Next Generation Sequencing (NGS) Solution Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Next Generation Sequencing (NGS) Solution Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Sporadic Cancer
6.2.2 Inherited Cancer
6.2.3 Companion Diagnostics
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Next Generation Sequencing (NGS) Solution Market Size by Application (2018-2023)
6.3.2 World Next Generation Sequencing (NGS) Solution Market Size by Application (2024-2029)
6.3.3 World Next Generation Sequencing (NGS) Solution Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Illumina
7.1.1 Illumina Details
7.1.2 Illumina Major Business
7.1.3 Illumina Next Generation Sequencing (NGS) Solution Product and Services
7.1.4 Illumina Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Illumina Recent Developments/Updates
7.1.6 Illumina Competitive Strengths & Weaknesses
7.2 PerkinElmer
7.2.1 PerkinElmer Details
7.2.2 PerkinElmer Major Business
7.2.3 PerkinElmer Next Generation Sequencing (NGS) Solution Product and Services
7.2.4 PerkinElmer Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 PerkinElmer Recent Developments/Updates
7.2.6 PerkinElmer Competitive Strengths & Weaknesses
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Details
7.3.2 Thermo Fisher Scientific Major Business
7.3.3 Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Product and Services
7.3.4 Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Thermo Fisher Scientific Recent Developments/Updates
7.3.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.4 Roche Holding
7.4.1 Roche Holding Details
7.4.2 Roche Holding Major Business
7.4.3 Roche Holding Next Generation Sequencing (NGS) Solution Product and Services
7.4.4 Roche Holding Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Roche Holding Recent Developments/Updates
7.4.6 Roche Holding Competitive Strengths & Weaknesses
7.5 Agilent Technologies
7.5.1 Agilent Technologies Details
7.5.2 Agilent Technologies Major Business
7.5.3 Agilent Technologies Next Generation Sequencing (NGS) Solution Product and Services
7.5.4 Agilent Technologies Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Agilent Technologies Recent Developments/Updates
7.5.6 Agilent Technologies Competitive Strengths & Weaknesses
7.6 Myriad Genetics
7.6.1 Myriad Genetics Details
7.6.2 Myriad Genetics Major Business
7.6.3 Myriad Genetics Next Generation Sequencing (NGS) Solution Product and Services
7.6.4 Myriad Genetics Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Myriad Genetics Recent Developments/Updates
7.6.6 Myriad Genetics Competitive Strengths & Weaknesses
7.7 Foundation Medicine
7.7.1 Foundation Medicine Details
7.7.2 Foundation Medicine Major Business
7.7.3 Foundation Medicine Next Generation Sequencing (NGS) Solution Product and Services
7.7.4 Foundation Medicine Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Foundation Medicine Recent Developments/Updates
7.7.6 Foundation Medicine Competitive Strengths & Weaknesses
7.8 Oxford Nanopore Technologies
7.8.1 Oxford Nanopore Technologies Details
7.8.2 Oxford Nanopore Technologies Major Business
7.8.3 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Product and Services
7.8.4 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Oxford Nanopore Technologies Recent Developments/Updates
7.8.6 Oxford Nanopore Technologies Competitive Strengths & Weaknesses
7.9 Pacific Biosciences
7.9.1 Pacific Biosciences Details
7.9.2 Pacific Biosciences Major Business
7.9.3 Pacific Biosciences Next Generation Sequencing (NGS) Solution Product and Services
7.9.4 Pacific Biosciences Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Pacific Biosciences Recent Developments/Updates
7.9.6 Pacific Biosciences Competitive Strengths & Weaknesses
7.10 Paradigm Diagnostics
7.10.1 Paradigm Diagnostics Details
7.10.2 Paradigm Diagnostics Major Business
7.10.3 Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Product and Services
7.10.4 Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Paradigm Diagnostics Recent Developments/Updates
7.10.6 Paradigm Diagnostics Competitive Strengths & Weaknesses
7.11 BGI Group
7.11.1 BGI Group Details
7.11.2 BGI Group Major Business
7.11.3 BGI Group Next Generation Sequencing (NGS) Solution Product and Services
7.11.4 BGI Group Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 BGI Group Recent Developments/Updates
7.11.6 BGI Group Competitive Strengths & Weaknesses
7.12 Caris Life Sciences
7.12.1 Caris Life Sciences Details
7.12.2 Caris Life Sciences Major Business
7.12.3 Caris Life Sciences Next Generation Sequencing (NGS) Solution Product and Services
7.12.4 Caris Life Sciences Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Caris Life Sciences Recent Developments/Updates
7.12.6 Caris Life Sciences Competitive Strengths & Weaknesses
7.13 Partek
7.13.1 Partek Details
7.13.2 Partek Major Business
7.13.3 Partek Next Generation Sequencing (NGS) Solution Product and Services
7.13.4 Partek Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Partek Recent Developments/Updates
7.13.6 Partek Competitive Strengths & Weaknesses
7.14 Eurofins Scientific
7.14.1 Eurofins Scientific Details
7.14.2 Eurofins Scientific Major Business
7.14.3 Eurofins Scientific Next Generation Sequencing (NGS) Solution Product and Services
7.14.4 Eurofins Scientific Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Eurofins Scientific Recent Developments/Updates
7.14.6 Eurofins Scientific Competitive Strengths & Weaknesses
7.15 Qiagen
7.15.1 Qiagen Details
7.15.2 Qiagen Major Business
7.15.3 Qiagen Next Generation Sequencing (NGS) Solution Product and Services
7.15.4 Qiagen Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Qiagen Recent Developments/Updates
7.15.6 Qiagen Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Next Generation Sequencing (NGS) Solution Industry Chain
8.2 Next Generation Sequencing (NGS) Solution Upstream Analysis
8.3 Next Generation Sequencing (NGS) Solution Midstream Analysis
8.4 Next Generation Sequencing (NGS) Solution Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Next Generation Sequencing (NGS) Solution Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Next Generation Sequencing (NGS) Solution Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Next Generation Sequencing (NGS) Solution Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Next Generation Sequencing (NGS) Solution Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Next Generation Sequencing (NGS) Solution Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Next Generation Sequencing (NGS) Solution Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Next Generation Sequencing (NGS) Solution Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Next Generation Sequencing (NGS) Solution Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Next Generation Sequencing (NGS) Solution Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Next Generation Sequencing (NGS) Solution Players in 2022
Table 12. World Next Generation Sequencing (NGS) Solution Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Next Generation Sequencing (NGS) Solution Company Evaluation Quadrant
Table 14. Head Office of Key Next Generation Sequencing (NGS) Solution Player
Table 15. Next Generation Sequencing (NGS) Solution Market: Company Product Type Footprint
Table 16. Next Generation Sequencing (NGS) Solution Market: Company Product Application Footprint
Table 17. Next Generation Sequencing (NGS) Solution Mergers & Acquisitions Activity
Table 18. United States VS China Next Generation Sequencing (NGS) Solution Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Next Generation Sequencing (NGS) Solution Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Next Generation Sequencing (NGS) Solution Companies, Headquarters (States, Country)
Table 21. United States Based Companies Next Generation Sequencing (NGS) Solution Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Next Generation Sequencing (NGS) Solution Revenue Market Share (2018-2023)
Table 23. China Based Next Generation Sequencing (NGS) Solution Companies, Headquarters (Province, Country)
Table 24. China Based Companies Next Generation Sequencing (NGS) Solution Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Next Generation Sequencing (NGS) Solution Revenue Market Share (2018-2023)
Table 26. Rest of World Based Next Generation Sequencing (NGS) Solution Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Next Generation Sequencing (NGS) Solution Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Next Generation Sequencing (NGS) Solution Revenue Market Share (2018-2023)
Table 29. World Next Generation Sequencing (NGS) Solution Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Next Generation Sequencing (NGS) Solution Market Size by Type (2018-2023) & (USD Million)
Table 31. World Next Generation Sequencing (NGS) Solution Market Size by Type (2024-2029) & (USD Million)
Table 32. World Next Generation Sequencing (NGS) Solution Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Next Generation Sequencing (NGS) Solution Market Size by Application (2018-2023) & (USD Million)
Table 34. World Next Generation Sequencing (NGS) Solution Market Size by Application (2024-2029) & (USD Million)
Table 35. Illumina Basic Information, Area Served and Competitors
Table 36. Illumina Major Business
Table 37. Illumina Next Generation Sequencing (NGS) Solution Product and Services
Table 38. Illumina Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Illumina Recent Developments/Updates
Table 40. Illumina Competitive Strengths & Weaknesses
Table 41. PerkinElmer Basic Information, Area Served and Competitors
Table 42. PerkinElmer Major Business
Table 43. PerkinElmer Next Generation Sequencing (NGS) Solution Product and Services
Table 44. PerkinElmer Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. PerkinElmer Recent Developments/Updates
Table 46. PerkinElmer Competitive Strengths & Weaknesses
Table 47. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 48. Thermo Fisher Scientific Major Business
Table 49. Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Product and Services
Table 50. Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Thermo Fisher Scientific Recent Developments/Updates
Table 52. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 53. Roche Holding Basic Information, Area Served and Competitors
Table 54. Roche Holding Major Business
Table 55. Roche Holding Next Generation Sequencing (NGS) Solution Product and Services
Table 56. Roche Holding Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Roche Holding Recent Developments/Updates
Table 58. Roche Holding Competitive Strengths & Weaknesses
Table 59. Agilent Technologies Basic Information, Area Served and Competitors
Table 60. Agilent Technologies Major Business
Table 61. Agilent Technologies Next Generation Sequencing (NGS) Solution Product and Services
Table 62. Agilent Technologies Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Agilent Technologies Recent Developments/Updates
Table 64. Agilent Technologies Competitive Strengths & Weaknesses
Table 65. Myriad Genetics Basic Information, Area Served and Competitors
Table 66. Myriad Genetics Major Business
Table 67. Myriad Genetics Next Generation Sequencing (NGS) Solution Product and Services
Table 68. Myriad Genetics Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Myriad Genetics Recent Developments/Updates
Table 70. Myriad Genetics Competitive Strengths & Weaknesses
Table 71. Foundation Medicine Basic Information, Area Served and Competitors
Table 72. Foundation Medicine Major Business
Table 73. Foundation Medicine Next Generation Sequencing (NGS) Solution Product and Services
Table 74. Foundation Medicine Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Foundation Medicine Recent Developments/Updates
Table 76. Foundation Medicine Competitive Strengths & Weaknesses
Table 77. Oxford Nanopore Technologies Basic Information, Area Served and Competitors
Table 78. Oxford Nanopore Technologies Major Business
Table 79. Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Product and Services
Table 80. Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Oxford Nanopore Technologies Recent Developments/Updates
Table 82. Oxford Nanopore Technologies Competitive Strengths & Weaknesses
Table 83. Pacific Biosciences Basic Information, Area Served and Competitors
Table 84. Pacific Biosciences Major Business
Table 85. Pacific Biosciences Next Generation Sequencing (NGS) Solution Product and Services
Table 86. Pacific Biosciences Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Pacific Biosciences Recent Developments/Updates
Table 88. Pacific Biosciences Competitive Strengths & Weaknesses
Table 89. Paradigm Diagnostics Basic Information, Area Served and Competitors
Table 90. Paradigm Diagnostics Major Business
Table 91. Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Product and Services
Table 92. Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Paradigm Diagnostics Recent Developments/Updates
Table 94. Paradigm Diagnostics Competitive Strengths & Weaknesses
Table 95. BGI Group Basic Information, Area Served and Competitors
Table 96. BGI Group Major Business
Table 97. BGI Group Next Generation Sequencing (NGS) Solution Product and Services
Table 98. BGI Group Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. BGI Group Recent Developments/Updates
Table 100. BGI Group Competitive Strengths & Weaknesses
Table 101. Caris Life Sciences Basic Information, Area Served and Competitors
Table 102. Caris Life Sciences Major Business
Table 103. Caris Life Sciences Next Generation Sequencing (NGS) Solution Product and Services
Table 104. Caris Life Sciences Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Caris Life Sciences Recent Developments/Updates
Table 106. Caris Life Sciences Competitive Strengths & Weaknesses
Table 107. Partek Basic Information, Area Served and Competitors
Table 108. Partek Major Business
Table 109. Partek Next Generation Sequencing (NGS) Solution Product and Services
Table 110. Partek Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Partek Recent Developments/Updates
Table 112. Partek Competitive Strengths & Weaknesses
Table 113. Eurofins Scientific Basic Information, Area Served and Competitors
Table 114. Eurofins Scientific Major Business
Table 115. Eurofins Scientific Next Generation Sequencing (NGS) Solution Product and Services
Table 116. Eurofins Scientific Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Eurofins Scientific Recent Developments/Updates
Table 118. Qiagen Basic Information, Area Served and Competitors
Table 119. Qiagen Major Business
Table 120. Qiagen Next Generation Sequencing (NGS) Solution Product and Services
Table 121. Qiagen Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Next Generation Sequencing (NGS) Solution Upstream (Raw Materials)
Table 123. Next Generation Sequencing (NGS) Solution Typical Customers
Table 1. World Next Generation Sequencing (NGS) Solution Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Next Generation Sequencing (NGS) Solution Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Next Generation Sequencing (NGS) Solution Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Next Generation Sequencing (NGS) Solution Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Next Generation Sequencing (NGS) Solution Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Next Generation Sequencing (NGS) Solution Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Next Generation Sequencing (NGS) Solution Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Next Generation Sequencing (NGS) Solution Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Next Generation Sequencing (NGS) Solution Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Next Generation Sequencing (NGS) Solution Players in 2022
Table 12. World Next Generation Sequencing (NGS) Solution Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Next Generation Sequencing (NGS) Solution Company Evaluation Quadrant
Table 14. Head Office of Key Next Generation Sequencing (NGS) Solution Player
Table 15. Next Generation Sequencing (NGS) Solution Market: Company Product Type Footprint
Table 16. Next Generation Sequencing (NGS) Solution Market: Company Product Application Footprint
Table 17. Next Generation Sequencing (NGS) Solution Mergers & Acquisitions Activity
Table 18. United States VS China Next Generation Sequencing (NGS) Solution Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Next Generation Sequencing (NGS) Solution Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Next Generation Sequencing (NGS) Solution Companies, Headquarters (States, Country)
Table 21. United States Based Companies Next Generation Sequencing (NGS) Solution Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Next Generation Sequencing (NGS) Solution Revenue Market Share (2018-2023)
Table 23. China Based Next Generation Sequencing (NGS) Solution Companies, Headquarters (Province, Country)
Table 24. China Based Companies Next Generation Sequencing (NGS) Solution Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Next Generation Sequencing (NGS) Solution Revenue Market Share (2018-2023)
Table 26. Rest of World Based Next Generation Sequencing (NGS) Solution Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Next Generation Sequencing (NGS) Solution Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Next Generation Sequencing (NGS) Solution Revenue Market Share (2018-2023)
Table 29. World Next Generation Sequencing (NGS) Solution Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Next Generation Sequencing (NGS) Solution Market Size by Type (2018-2023) & (USD Million)
Table 31. World Next Generation Sequencing (NGS) Solution Market Size by Type (2024-2029) & (USD Million)
Table 32. World Next Generation Sequencing (NGS) Solution Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Next Generation Sequencing (NGS) Solution Market Size by Application (2018-2023) & (USD Million)
Table 34. World Next Generation Sequencing (NGS) Solution Market Size by Application (2024-2029) & (USD Million)
Table 35. Illumina Basic Information, Area Served and Competitors
Table 36. Illumina Major Business
Table 37. Illumina Next Generation Sequencing (NGS) Solution Product and Services
Table 38. Illumina Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Illumina Recent Developments/Updates
Table 40. Illumina Competitive Strengths & Weaknesses
Table 41. PerkinElmer Basic Information, Area Served and Competitors
Table 42. PerkinElmer Major Business
Table 43. PerkinElmer Next Generation Sequencing (NGS) Solution Product and Services
Table 44. PerkinElmer Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. PerkinElmer Recent Developments/Updates
Table 46. PerkinElmer Competitive Strengths & Weaknesses
Table 47. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 48. Thermo Fisher Scientific Major Business
Table 49. Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Product and Services
Table 50. Thermo Fisher Scientific Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Thermo Fisher Scientific Recent Developments/Updates
Table 52. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 53. Roche Holding Basic Information, Area Served and Competitors
Table 54. Roche Holding Major Business
Table 55. Roche Holding Next Generation Sequencing (NGS) Solution Product and Services
Table 56. Roche Holding Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Roche Holding Recent Developments/Updates
Table 58. Roche Holding Competitive Strengths & Weaknesses
Table 59. Agilent Technologies Basic Information, Area Served and Competitors
Table 60. Agilent Technologies Major Business
Table 61. Agilent Technologies Next Generation Sequencing (NGS) Solution Product and Services
Table 62. Agilent Technologies Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Agilent Technologies Recent Developments/Updates
Table 64. Agilent Technologies Competitive Strengths & Weaknesses
Table 65. Myriad Genetics Basic Information, Area Served and Competitors
Table 66. Myriad Genetics Major Business
Table 67. Myriad Genetics Next Generation Sequencing (NGS) Solution Product and Services
Table 68. Myriad Genetics Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Myriad Genetics Recent Developments/Updates
Table 70. Myriad Genetics Competitive Strengths & Weaknesses
Table 71. Foundation Medicine Basic Information, Area Served and Competitors
Table 72. Foundation Medicine Major Business
Table 73. Foundation Medicine Next Generation Sequencing (NGS) Solution Product and Services
Table 74. Foundation Medicine Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Foundation Medicine Recent Developments/Updates
Table 76. Foundation Medicine Competitive Strengths & Weaknesses
Table 77. Oxford Nanopore Technologies Basic Information, Area Served and Competitors
Table 78. Oxford Nanopore Technologies Major Business
Table 79. Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Product and Services
Table 80. Oxford Nanopore Technologies Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Oxford Nanopore Technologies Recent Developments/Updates
Table 82. Oxford Nanopore Technologies Competitive Strengths & Weaknesses
Table 83. Pacific Biosciences Basic Information, Area Served and Competitors
Table 84. Pacific Biosciences Major Business
Table 85. Pacific Biosciences Next Generation Sequencing (NGS) Solution Product and Services
Table 86. Pacific Biosciences Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Pacific Biosciences Recent Developments/Updates
Table 88. Pacific Biosciences Competitive Strengths & Weaknesses
Table 89. Paradigm Diagnostics Basic Information, Area Served and Competitors
Table 90. Paradigm Diagnostics Major Business
Table 91. Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Product and Services
Table 92. Paradigm Diagnostics Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Paradigm Diagnostics Recent Developments/Updates
Table 94. Paradigm Diagnostics Competitive Strengths & Weaknesses
Table 95. BGI Group Basic Information, Area Served and Competitors
Table 96. BGI Group Major Business
Table 97. BGI Group Next Generation Sequencing (NGS) Solution Product and Services
Table 98. BGI Group Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. BGI Group Recent Developments/Updates
Table 100. BGI Group Competitive Strengths & Weaknesses
Table 101. Caris Life Sciences Basic Information, Area Served and Competitors
Table 102. Caris Life Sciences Major Business
Table 103. Caris Life Sciences Next Generation Sequencing (NGS) Solution Product and Services
Table 104. Caris Life Sciences Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Caris Life Sciences Recent Developments/Updates
Table 106. Caris Life Sciences Competitive Strengths & Weaknesses
Table 107. Partek Basic Information, Area Served and Competitors
Table 108. Partek Major Business
Table 109. Partek Next Generation Sequencing (NGS) Solution Product and Services
Table 110. Partek Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Partek Recent Developments/Updates
Table 112. Partek Competitive Strengths & Weaknesses
Table 113. Eurofins Scientific Basic Information, Area Served and Competitors
Table 114. Eurofins Scientific Major Business
Table 115. Eurofins Scientific Next Generation Sequencing (NGS) Solution Product and Services
Table 116. Eurofins Scientific Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Eurofins Scientific Recent Developments/Updates
Table 118. Qiagen Basic Information, Area Served and Competitors
Table 119. Qiagen Major Business
Table 120. Qiagen Next Generation Sequencing (NGS) Solution Product and Services
Table 121. Qiagen Next Generation Sequencing (NGS) Solution Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Next Generation Sequencing (NGS) Solution Upstream (Raw Materials)
Table 123. Next Generation Sequencing (NGS) Solution Typical Customers
LIST OF FIGURES
Figure 1. Next Generation Sequencing (NGS) Solution Picture
Figure 2. World Next Generation Sequencing (NGS) Solution Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Next Generation Sequencing (NGS) Solution Total Market Size (2018-2029) & (USD Million)
Figure 4. World Next Generation Sequencing (NGS) Solution Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Next Generation Sequencing (NGS) Solution Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Next Generation Sequencing (NGS) Solution Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Next Generation Sequencing (NGS) Solution Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Next Generation Sequencing (NGS) Solution Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Next Generation Sequencing (NGS) Solution Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Next Generation Sequencing (NGS) Solution Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Next Generation Sequencing (NGS) Solution Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Next Generation Sequencing (NGS) Solution Revenue (2018-2029) & (USD Million)
Figure 13. Next Generation Sequencing (NGS) Solution Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 16. World Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 18. China Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 23. India Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Next Generation Sequencing (NGS) Solution by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Next Generation Sequencing (NGS) Solution Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Next Generation Sequencing (NGS) Solution Markets in 2022
Figure 27. United States VS China: Next Generation Sequencing (NGS) Solution Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Next Generation Sequencing (NGS) Solution Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Next Generation Sequencing (NGS) Solution Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Next Generation Sequencing (NGS) Solution Market Size Market Share by Type in 2022
Figure 31. Whole Genome Sequencing
Figure 32. Whole Exome Sequencing
Figure 33. Targeted Sequencing and Resequencing Centrifuges
Figure 34. World Next Generation Sequencing (NGS) Solution Market Size Market Share by Type (2018-2029)
Figure 35. World Next Generation Sequencing (NGS) Solution Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Next Generation Sequencing (NGS) Solution Market Size Market Share by Application in 2022
Figure 37. Sporadic Cancer
Figure 38. Inherited Cancer
Figure 39. Companion Diagnostics
Figure 40. Others
Figure 41. Next Generation Sequencing (NGS) Solution Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
Figure 1. Next Generation Sequencing (NGS) Solution Picture
Figure 2. World Next Generation Sequencing (NGS) Solution Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Next Generation Sequencing (NGS) Solution Total Market Size (2018-2029) & (USD Million)
Figure 4. World Next Generation Sequencing (NGS) Solution Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Next Generation Sequencing (NGS) Solution Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Next Generation Sequencing (NGS) Solution Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Next Generation Sequencing (NGS) Solution Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Next Generation Sequencing (NGS) Solution Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Next Generation Sequencing (NGS) Solution Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Next Generation Sequencing (NGS) Solution Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Next Generation Sequencing (NGS) Solution Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Next Generation Sequencing (NGS) Solution Revenue (2018-2029) & (USD Million)
Figure 13. Next Generation Sequencing (NGS) Solution Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 16. World Next Generation Sequencing (NGS) Solution Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 18. China Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 23. India Next Generation Sequencing (NGS) Solution Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Next Generation Sequencing (NGS) Solution by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Next Generation Sequencing (NGS) Solution Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Next Generation Sequencing (NGS) Solution Markets in 2022
Figure 27. United States VS China: Next Generation Sequencing (NGS) Solution Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Next Generation Sequencing (NGS) Solution Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Next Generation Sequencing (NGS) Solution Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Next Generation Sequencing (NGS) Solution Market Size Market Share by Type in 2022
Figure 31. Whole Genome Sequencing
Figure 32. Whole Exome Sequencing
Figure 33. Targeted Sequencing and Resequencing Centrifuges
Figure 34. World Next Generation Sequencing (NGS) Solution Market Size Market Share by Type (2018-2029)
Figure 35. World Next Generation Sequencing (NGS) Solution Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Next Generation Sequencing (NGS) Solution Market Size Market Share by Application in 2022
Figure 37. Sporadic Cancer
Figure 38. Inherited Cancer
Figure 39. Companion Diagnostics
Figure 40. Others
Figure 41. Next Generation Sequencing (NGS) Solution Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
